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ABBREVIATIONS 
 
ALP  = Alkaline Phosphatase. 
ALT  = Alanine Aminotransferase 
AST  = Aspartate Aminotransferase 
ATP  = Adenosine Triphosphate 
CAT  = Catalase 
CDK  = Cyclin-Dependent Kinase 
COX  = Cyclooxygenase 
DEN  = Diethylnitrosamine 
DNA  = Deoxyribonucleic Acid 
GI  = Gastro Intestinal 
GSH  = Reduced Glutathione  
GSSG  = Oxidized Glutathione 
GST  = Glutathione S-Transferases 
HBV  = Hepatitis B Vaccine 
HCC  = Hepatocellular Carcinoma 
HCV  = Hepatitis C Vaccine 
HIFU  = High Intensity Focused Ultrasound 
IL   = Interleukin 
LPO  = Lipid Peroxidation 
MDA  = Malondialdehyde 
MDM2 = Murine Double Minute 
NADPH = Nicotinamide Adenine Dinucleotide Phosphate-Oxidase 
O4-Etdt = O4- Ethyldeoxythymidine 
OS  = Oxidative Stress 
PB  = Phenobarbital 
PEI  = Percutaneous Ethanol Injection 
PUFA  = Polyunsaturated Fatty acids 
RFA  = Radiofrequency Ablation 
RNA  = Ribonucleic Acid 
ROS  = Reactive Oxygen Species 
SOD  = Superoxide Dismutase 
TACE  = Transcatheter Arterial Chemoembolization  
TGF-β  = Tumor Growth Factor - Beta 
TNF-α  = Tumor Necrosis Factor - Alpha 
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1. INTRODUCTION 
 
Cancer or malignant neoplasm as it is termed medically is a class of diseases 
where a group of cells exhibit uncontrolled growth, invasion (intrusion on and 
destruction of adjacent tissues), and sometimes metastasis (spread to other locations in 
the body via lymph or blood). These three malignant properties of cancers differentiate 
them from benign tumors, which are self-limited, do not invade or metastasize. The 
branch of medicine concerned with the study, diagnosis, treatment, and prevention of 
cancer is oncology. Cancer affects people of all ages, even fetuses, but the risk for most 
varieties increases with age. Statistical data proves that cancer causes about 13% of all 
deaths. Cancer affects several organs of the body and cancers are thus named according 
to the organ it affects (Figure 1). The incidence of cancer development differs in males 
and females, however it has been reported that Males are more prone to cancer as 
compared to females. 
 
 
Figure 1: Types of Cancer (Men and Women) 
1.1. Causes of cancer   
 
Nearly all cancers are caused by abnormalities in the genetic material of the 
transformed cells, which may be due to the effects of carcinogens, such as tobacco 
smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic 
abnormalities may be randomly acquired through errors in DNA replication, or are 
inherited, and thus present in all cells from birth. The heritability of cancers is usually 
affected by complex interactions between carcinogens and the host's genome.  
New aspects of the genetics of cancer pathogenesis, such as DNA methylation, 
and micro RNAs are increasingly recognized as important. Research into the 
pathogenesis of cancer has been divided into three broad areas of focus. The first area 
of research focuses on the agents and events, which cause or facilitate genetic changes 
in cells destined to become cancer. Second, is to uncover the precise nature of the 
genetic damage, and the genes, which are affected by it. The third focus is on the 
consequences of those genetic changes on the biology of the cell, both in generating the 
hereditary defining properties of a cancer cell, and in facilitating additional genetic 
events, leading to further progression of the cancer. 
 
1.2. Symptoms of cancer 
 
Roughly, cancer symptoms can be divided into three groups: - 
 
• Local symptoms: - unusual lumps or swelling (tumor), hemorrhage (bleeding), 
pain and/or ulceration. Compression of surrounding tissues may cause 
symptoms such as jaundice (yellowing the eyes and skin). 
 
• Symptoms of metastasis (spreading): - Enlarged lymph nodes, cough and 
hemoptysis, hepatomegaly (enlarged liver), bone pain, fracture of affected 
bones and neurological symptoms. Although advanced cancer may cause pain, 
it is often not the first symptom.  
 
• Systemic symptoms: - weight loss, poor appetite, fatigue and cachexia 
(wasting), excessive sweating (night sweats), anemia and specific 
paraneoplastic phenomena, i.e. specific conditions that are due to an active 
cancer, such as thrombosis or hormonal changes.  
 
1.3. Pathophysiology of cancer  
 
Cancers are caused by a series of mutations, which alters the behavior of the 
cells. Cancer is fundamentally a disease related to regulation of tissue growth. 
Transformation of a normal cell into a cancerous cell is due to the alteration of genes 
that deal with regulation of cell growth and differentiation, (Croce CM, 2008). There 
are two broad categories of genes, which are affected by the alteration – “Oncogenes” 
and “tumor suppressor genes”, (Knudson AG, 2001). 
1.3.1. Oncogenes:  
 
Oncogenes may be normal genes, which are expressed at inappropriately high 
levels, or altered genes, which have novel properties. In either case, expression of these 
genes promotes the malignant phenotype of cancer cells. Oncogenes primarily promote 
cell growth by several ways. Most produce hormones ("chemical messengers") between 
cells, which encourage mitosis, the effect of which depends on the signal transduction 
of the receiving tissue, or cells. First oncogene that defined in cancer research was the 
ras oncogene. Mutations in the ras family of proto-oncogenes (comprising H-Ras, N-
Ras, and K-Ras) are very common, being found in 20% to 30% of all human tumors, 
(Bos J, 1989).  
 
Usually, oncogenes are dominant, as they contain gain-of-function mutations, 
while mutated tumor suppressors are recessive, as they contain loss-of-function 
mutations. Each cell has two copies of the same gene, one from each parent, and under 
most cases gain of function mutations in just one copy of a particular proto-oncogene is 
enough to make that gene a true oncogene. On the other hand, loss of function 
mutations needs to happen in both copies of a tumor suppressor gene to render that 
gene completely non-functional. However, cases exist in which one mutated copy of a 
tumor suppressor gene can render the other, wild-type copy non-functional. This 
phenomenon is called the dominant negative effect and is observed in many p53 
mutations. 
 
1.3.2. Tumor suppressor genes:  
Tumor suppressor genes code for anti-proliferation signals and proteins that 
suppress mitosis and cell growth. These are often disabled by cancer-promoting genetic 
changes. Tumor suppressors are transcription factors that are activated by cellular stress 
or DNA damage. The functions of such genes is to arrest the progression of the cell 
cycle in order to carry out DNA repair, preventing mutations from being passed on to 
daughter cells. The p53 protein, one of the most important studied tumor suppressor 
genes, is a transcription factor activated by many cellular stressors including hypoxia 
and ultraviolet radiation damage. p53 clearly has two functions: one a nuclear role as a 
transcription factor, and the other a cytoplasmic role in regulating the cell cycle, cell 
division, and apoptosis.  
Development of cancer was proposed in 1971 to depend on at least two 
mutational events. In what became known as the Knudson two-hit hypothesis, an 
inherited, germ-line mutation in a tumor suppressor gene would only cause cancer if 
another mutation event occurred later in the organism's life, inactivating the other allele 
of that tumor suppressor gene, (Knudson A, 1971). 
 
Figure 2: Pathogenesis of Cancer 
 
1.4. Epigenetics of cancer 
 
Epigenetics is the study of the regulation of gene expression through chemical, 
non-mutational changes in DNA structure. The theory of epigenetics in cancer 
pathogenesis is that non-mutational changes to DNA that lead to alterations in gene 
expression. Normally, oncogenes are silent, for example, because of DNA methylation. 
Loss of that methylation can induce the aberrant expression of oncogenes, leading to 
cancer pathogenesis. Known mechanisms of epigenetic change include DNA 
methylation, and methylation or acetylation of histone proteins bound to chromosomal 
DNA at specific locations. 
1.5. Treatment of cancer 
 
 Surgery, immunotherapy, chemotherapy, monoclonal antibody therapy, and 
radiation therapy are methods generally used against various cancers as treatment. 
Choice however depends on the grade, size, and stage of the disease as well as the 
general state of the patient (performance status). Because “cancer” is said to be class of 
diseases, it is unlikely that there will be a single cure for cancer any more than there 
will be a single treatment for all infectious diseases. 
1.6. Liver 
Liver is an organ in the upper abdomen that aids in digestion and removes waste 
products and worn-out cells from the blood. The liver is the largest solid organ in the 
body. The liver generally weighs about three and a half pounds (1.6 kilograms) in 
adults. It measures about 8 inches (20 cm) horizontally (across) and 6.5 inches (17 cm) 
vertically (down) and is 4.5 inches (12 cm) thick. Liver is known to be one of the 
important organs of the biliary system. 
 
Figure 3: The Biliary System 
Functions 
9 Manufacture (synthesize) proteins, including albumin (to help maintain the 
volume of blood) and blood clotting factors 
 
9 The liver stores a multitude of substances, including glucose (as glycogen), 
vitamin A (1-2 years' supply), vitamin D (1-4 months' supply), vitamin B12, 
iron, and copper. 
9 Synthesize, store, and process fats, including fatty acids and cholesterol. 
 
9 Metabolize and store carbohydrates, which are used as the source for the sugar 
(glucose) in blood that red blood cells and the brain use. 
 
9 Form and secrete bile that contains bile acids to aid in the intestinal absorption 
(taking in) of fats and the fat-soluble vitamins A, D, E, and K. 
 
9 Eliminate, by metabolizing and/or secreting, the potentially harmful 
biochemical products produced by the body, such as bilirubin from the 
breakdown of old red blood cells and ammonia from the breakdown of proteins. 
 
9 Detoxify, by metabolizing and/or secreting, drugs, alcohol, and environmental 
toxins. 
 
1.7. Liver cancer 
 
Liver cancer is characterized by the presence of malignant hepatic tumors -- 
tumors or growths on or in the liver (medical terms pertaining to the liver often start in 
hepato- or hepatic from the Greek word for liver, hēpar, stem hēpat-). They may be 
discovered on medical imaging (even for a different reason than the cancer itself), or 
may be present in patients as an abdominal mass, hepatomegaly, abdominal pain, 
jaundice, or some other liver dysfunction. 
 
1.7.1. Classification:  
 
Liver cancers can be classified as follows: - 
 
¾ Most cases are metastases from other tumors, frequently of the GI tract (like 
colon cancer, carcinoid tumors mainly of the appendix, etc.), but also from 
breast cancer, ovarian cancer, lung cancer, renal cancer, prostate cancer, etc.  
¾ The most frequent, malignant, primary liver cancer is hepatocellular carcinoma 
(also named hepatoma, which is a misnomer because adenomas are usually 
benign).  
¾ More rare primary forms of liver cancer include cholangiocarcinoma, mixed 
tumors, tumors of mesenchymal tissue, sarcoma, and hepatoblastoma, and a rare 
malignant tumor in children.  
1.7.2. Causes 
 
¾ The most common cause for liver cancer is its cirrhosis in sixty to eighty 
percent of patients. Cirrhosis results from scar formation within the liver, most 
commonly due to chronic alcohol use. 
¾ Chronic infection with hepatitis C virus (HCV) is also a common cause of liver 
cancer in the United States.  
¾ Presence of the fungus on food in these regions leads to chronic exposure to the 
toxin, resulting in an increased risk of developing liver cancer. 
¾ Worldwide, other risk factors, such as chronic infection with hepatitis B virus 
(HBV) and aflatoxin B1 food contamination are more common.  
¾ Tobacco use has also been associated with increased risk; however, it is not as 
strong of a risk factor as alcohol-induced liver cirrhosis.  
¾ Other environmental factors include exposure to thorium dioxide, vinyl 
chloride, arsenic exposure, and use of anabolic steroids.  
¾ Several inherited diseases can increase the risk of liver cirrhosis, and therefore 
increase the risk of developing liver cancer. These diseases include 
hemochromatosis, Wilson’s disease, and alpha-1-antitrypsin deficiency. 
¾ Patients with a family history of liver cancer may also be at increased risk. 
Finally, males are about twice as likely to develop liver cancer as females.  
 
1.7.3. Hepatocellular carcinoma 
 
Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most 
common type of primary liver cancer and accounts for 70% of all liver cancers. Most 
cases of HCC are secondary to either a viral hepatitide infection or cirrhosis 
(alcoholism being the most common cause of hepatic cirrhosis). Hepatocarcinogenesis 
is mediated by loss of heterozygosity, somatic mutation, de novo methylation, and/or 
functional inactivation.  
 
1.7.4. Treatments for Hepatocellular carcinoma 
 
¾ Liver transplantation 
¾ Percutaneous ethanol injection (PEI) 
¾ Transcatheter arterial chemoembolization (TACE) 
¾ Sealed source radiotherapy 
¾ Radiofrequency ablation (RFA) 
¾ Intra-arterial iodine-131–lipiodol administration 
¾ Combined PEI and TACE can be used for tumors larger than 4 cm in diameter 
¾ High intensity focused ultrasound (HIFU) 
¾ Hormonal therapy and Adjuvant chemotherapy 
¾ Cryosurgery: Cryosurgery is a new technique that can destroy tumors in a 
variety of sites (brain, breast, kidney, and liver) where the destruction of 
abnormal tissue using sub-zero temperatures is performed.  
 
1.7.5. Pathology of liver cancer 
Macroscopically, liver cancer appears as a nodular or infiltrative tumor. The 
nodular type may be solitary (large mass) or multiple (when developed as a 
complication of cirrhosis). Tumor nodules are round to oval, grey or green (if the tumor 
produces bile), well circumscribed, but not encapsulated. The diffuse type is poorly 
circumscribed and infiltrates the portal veins, or the hepatic veins (rarely). 
Microscopically, there are four architectural and cytological types (patterns) of 
hepatocellular carcinoma: fibrolamellar, pseudoglandular (adenoid), pleomorphic (giant 
cell) and clear cell. In well-differentiated forms, tumor cells resemble hepatocytes, form 
trabeculae, cords and nests, and may contain bile pigment in cytoplasm. In poorly 
differentiated forms, malignant epithelial cells are discohesive, pleomorphic, anaplastic, 
giant. The tumor has a scant stroma and central necrosis because of the poor 
vascularization. 
1.7.6. Pathogenesis of hepatocellular carcinoma 
Hepatocellular carcinoma, like any other cancer, develops, when there is a 
mutation to the cellular machinery that causes the cell to replicate at a higher rate 
and/or results in the cell avoiding apoptosis. Accumulation of genetic alterations in 
these preneoplastic lesions is believed to lead to the development of HCC. 
Hepatocarcinogenesis may begin in preneoplastic lesions such as macroregenerative 
nodules, low-grade and high-grade dysplastic nodules, (Takayama et al., 1990; Orsatti 
et al., 1993). Genomic alterations occur randomly, and they accumulate in dysplastic 
hepatocytes and HCC. 
 
Figure 4: -Sequential changes in liver leading to HCC 
HCC are believed to be caused by the accumulation of genetic changes resulting 
in altered expression of cancer-related genes, such as oncogenes or tumor suppressor 
genes, as well as genes involved in different regulatory pathways. The genetic changes 
involved can be divided in at least 4 different pathways, each pathway contributing to a 
limited number of tumors. These pathways are - 
1. The p53 pathway involved in response to DNA damage,  
2. The retinoblastoma pathway involved in control of the cell cycle,  
3. The transforming growth factor-beta (TGF-beta) pathway involved in growth 
inhibition, and 
4. The Wnt pathway involved in cell-cell adhesion and signal transduction. 
Several different genes have been implicated in the pathogenesis of HCC, and may 
be divided into four major groups: genes regulating DNA damage response; genes 
involved in cell cycle control; genes involved in growth inhibition and apoptosis, and 
genes responsible for cell-cell interaction and signal transduction, (Raphael Saffroy, 
2006). Although genetic changes may occur independently of etiologic conditions, 
some molecular mechanisms have been more frequently related to a specific etiology. 
For example, molecular pathways of HBV- and HCV-induced hepatocarcinogenesis 
involving above-mentioned pathways are different from those associated with 
alcoholism, (Wang et al., 2002; Suriawinata et al., 2004, Morgan et al., 2004).  
p53 
p53 has been described as "the guardian of the genome," "the guardian angel 
gene," and the "master watchman," referring to its role in conserving stability by 
preventing genome mutation, (Read, A. P, 1999). p53 clearly has two functions: one a 
nuclear role as a transcription factor, and the other a cytoplasmic role in regulating the 
cell cycle, cell division, and apoptosis. The Warburg hypothesis is the preferential use 
of glycolysis for energy to sustain cancer growth. p53 has been shown to regulate the 
shift from the respiratory to the glycolytic pathway. However, a mutation can damage 
the tumor suppressor gene itself, or the signal pathway, which activates it, "switching it 
off". The invariable consequence of this is that DNA repair is hindered or inhibited: 
DNA damage accumulates without repair, inevitably leading to cancer. 
 
 
Figure 5 Action of mdm2 on p53 
 
p53 is central to many of the cell's anti-cancer mechanisms. In normal cells, p53 
is usually inactive, bound to the protein MDM2 (also called HDM2 in humans), which 
prevents its action and promotes its degradation by acting as ubiquitin ligase. Active 
p53 is induced after the effects of various cancer-causing agents (UV radiation, 
oncogenes, and some DNA-damaging drugs). This damage is sensed by 'checkpoints' in 
a cell's cycle, causing proteins such as ATM, CHK1, and CHK2 to phosphorylate p53 
at sites that are close to or within the MDM2-binding region and p300-binding region 
of the protein. Oncogenes also stimulate p53 activation, mediated by the protein 
p14ARF. Some oncogenes can also stimulate the transcription of proteins, which bind 
to MDM2 and inhibit its activity. Once activated p53 activates expression of several 
genes including one encoding for p21. p21 binds to the G1-S/CDK and S/CDK 
complexes (molecules important for the G1/S transition in the cell cycle) inhibiting 
their activity.  
 
p53 has been proved to play important role in apoptosis, genetic stability, and 
inhibition of angiogenesis. In humans, p53 is encoded by the TP53 gene located on the 
short arm of chromosome 17. The p53 gene has been mapped to chromosome 17. In the 
cell, p53 protein binds DNA, which in turn stimulates another gene to produce a protein 
called p21 that interacts with a cell division-stimulating protein (cdk2). When p21 is 
complexed with cdk2 the cell cannot pass through to the next stage of cell division. 
Mutant p53 can no longer bind DNA in an effective way, and therefore the p21 protein 
is not made available to act as the 'stop signal' for cell division. Thus, cells divide 
uncontrollably, and form tumors. 
Functions 
p53 has many anti-cancer mechanisms: 
9 It can activate DNA repair proteins when DNA has sustained damage.  
9 It can also hold the cell cycle at the G1/S regulation point on DNA damage 
recognition. 
9 It can initiate apoptosis, the programmed cell death, if the DNA damage proves 
to be irreparable. 
1.7.7. Apoptosis 
Apoptosis is a form of programmed cell death in multi cellular organisms and 
involves a series of biochemical events leading to characteristic cell morphology and 
death, in more specific terms, a series of biochemical events that lead to a variety of 
morphological changes, including blebbing, changes to the cell membrane. Loss of 
membrane asymmetry and attachment, cell shrinkage, nuclear fragmentation, chromatin 
condensation, and chromosomal DNA fragmentation are the changes that occur to the 
cell membrane. Research on apoptosis has increased substantially since the early 1990s. 
In addition to its importance as a biological phenomenon, defective apoptotic processes 
have been implicated in an extensive variety of diseases. Excessive apoptosis causes 
hypotrophy, such as in ischemic damage, whereas an insufficient amount results in 
uncontrolled cell proliferation, such as cancer. 
Functions 
 
9 Cell termination: Apoptosis occurs when a cell is damaged beyond repair, 
infected with a virus, or undergoing stressful conditions such as starvation. 
Damage to DNA induces apoptosis via the actions of the tumour-suppressing 
gene p53. Apoptosis also plays a role in preventing cancer. If a cell is unable to 
undergo apoptosis because of mutation or biochemical inhibition, it continues to 
divide and develop into a tumour. 
 
9 Homeostasis: In the adult organism, the number of cells is kept relatively 
constant through cell death and division. Cells must be replaced when they 
malfunction or become diseased, but proliferation must be offset by cell death, 
(Thompson, CB. 1995).Homeostasis is achieved when the rate of mitosis (cell 
division) in the tissue is balanced by cell death. 
 
9 Development: Development of an organ or tissue is often preceded by the 
extensive division and differentiation of a particular cell, the resultant mass is 
then "pruned" into the correct form by apoptosis. 
 
9 Lymphocyte interactions: The development of B-lymphocytes and T 
lymphocytes in a human body is a complex process that creates a large pool of 
diverse cells and subsequently eliminates those potentially damaging to the 
body. In T cells, apoptosis is initiated by the withdrawal of survival signals, 
(Werlin G et al, 2003). Cytotoxic T cells directly induce apoptosis by opening 
up pores in the target's membrane and releasing chemicals. 
 
1.8. Apoptotic process 
 
The process of apoptosis is controlled by a diverse range of cell signals, which 
may originate either extracellularly (extrinsic inducers) or intracellularly (intrinsic 
inducers). Extra cellular signals may include toxins, hormones, growth factors, nitric 
oxide, or cytokines, and therefore must either cross the plasma membrane or transduce 
to affect a response (Popov SG et al, 2002; Brüne B, 2003). A cell initiates intracellular 
apoptotic signaling in response to a stress, which may bring about cell suicide. The 
binding of nuclear receptors by glucocorticoids, heat, radiation, nutrient deprivation, 
viral infection, hypoxia, and increased intracellular calcium concentration, for example, 
by damage to the membrane can all trigger the release of intracellular apoptotic signals 
by a damaged cell. (Cotran et at; Mark P et al, 2003). 
 
1.9. Oxidative Stress 
 
Oxidative Stress (OS) is a general term used to describe the steady state level of 
oxidative damage in a cell, tissue, or organ, caused by the reactive oxygen species 
(ROS) (Davies, 2000). This damage affects a specific molecule or the entire organism. 
ROS, such as free radicals and peroxides, represent a class of molecules derived from 
the metabolism of oxygen and exist inherently in all aerobic organisms. There are many 
different sources by which the ROS are generated. Most come from the endogenous 
sources as by-products of normal and essential metabolic reactions, such as energy 
generation from mitochondria (Shouval & Elazar, 2007) or the detoxification reactions 
involving the liver cytochrome P-450 enzyme system.  
Exogenous sources include exposure to cigarette smoke, environmental 
pollutants such as emission from automobiles and industries, consumption of alcohol in 
excess, asbestos, exposure to ionizing radiation, and bacterial, fungal, or viral 
infections. The rate at which damage is caused is determined by how fast the reactive 
oxygen species are generated and then inactivated by endogenous defense agents called 
antioxidants. The rate at which damage is removed is dependent on the level of repair 
enzymes.  
ROS are the root cause of oxidative stress where ROS are generated from 
normal metabolism, cytochrome P450, immunopotentiation, or reperfusioninjury. 
These ROS are effectively scavenged by cellular antioxidant systems otherwise, their 
deleterious effect may lead to damage the lipids, proteins, and DNA, change in cellular 
functions or signal transductions and finally cell death or apoptosis (Shackelford et al., 
2000).  
However, severe oxidative stress may cause cell death and even moderate 
oxidation can trigger apoptosis, while more intense stresses may cause necrosis 
(Lennon SV, 1991). Oxygen-derived species, including free radicals causes DNA 
damage in frequent type of aerobic cells. When this type of damage occurs to DNA, it 
is called oxidative DNA damage and it can produce a multiplicity of modifications in 
DNA including base and sugar lesions, strand breaks, DNA-protein cross-links, and 
base-free sites. 
1.9.1. Free Radicals and Reactive Oxygen Species (Scandalios, 2002) 
Free radicals, i.e. atoms, or molecules with lone-paired electron are generally 
reactive substances and have short life span except for few that are stable for long time. 
Examples of reactive free radicals are super oxide, hydroxyl radical, protein radical, 
nitric oxide, and peroxinitrite radical etc. ROS that are not free radicals (without lone-
paired electrons) include hydrogen peroxide, singlet oxygen, and lipid hydroperoxide.  
 
They play important roles in signal transduction (including gene expression, 
protein synthesis), sensing of oxygen tension and regulation of functions controlled by 
oxygen concentration and are essential in synthesis of energy (mitochondrial electron 
transport chain) and essential molecules. They also act as immune boosters. ROS reacts 
quickly with other compounds in order to capture the needed electrons to gain stability. 
Generally, free radicals attack the nearest stable molecule, which looses its electron; it 
becomes a free radical itself, beginning a chain reaction cascade resulting in disruption 
of a living cells. 
 
Oxygen free radicals (Figure-5) are generated within the mitochondrial 
membrane where cytochrome oxidase catalyses the four electron reduction of oxygen 
(O2) to water (H2O). Intermediate compounds between reactions of O2 to H2O leads to 
three partially reduced species of oxygen, which are generated depending upon the 
number of electrons, transferred. These are: 
1) Superoxide oxygen (O2.-):  one electron. 
2) Hydrogen peroxide (H2O2):  two electrons. 
3) Hydroxyl radical (OH.): three electrons. 
A few other oxygen radicals which may be generated in reactions other than 
those during O2 to H2O are hypochlorous acid (HOCl), peroxynitrate ion (ONOO), 
nitric oxide (NO) generated by various body cells (endothelial cells, neurons, 
macrophages etc), and release of superoxide free radical in Fenton reaction.  
Most common radical derivatives of oxygen like superoxide free radical anion 
(O2.-), hydroxyl free radical (OH.), lipid peroxyl (LO), lipid alkoxy (LOO) and lipid 
peroxide (LOOH) as well as non-radical derivatives such as hydrogen peroxide (H2O2) 
and singlet oxygen (1O2) are collectively known as reactive oxygen species (ROS). 
These free radicals or reactive oxygen species are produced mainly from two important 
sources in the biological system. First source is from cellular metabolism like 
mitochondrial electron transport chain, endoplasmic reticulum oxidation, NADPH 
oxidase, xanthine oxidase, prostaglandin synthesis, reduced riboflavin, nitric oxide 
synthetase, reperfusion injury, cytochrome  P450, activated neutrophiles, and phagocytic 
cells and secondly from environmental sources like drugs, pesticides, transition metals, 
tobacco smoke, alcohol, radiations and high temperature. 
Superoxide anions (O2.-): Superoxide anion is the first reduction product of O2. 
It is a base with the equilibrium with its conjugate acid, the hydroperoxy radical HO2•, 
whose pKa is 4.8. In aqueous solution, at neutral or slightly acid pH, O2.- is a relatively 
non-reactive species and dismutates to H2O2. This reaction may occur spontaneously or 
be catalyzed by intracellular enzyme, SOD. 
Hydrogen peroxide (H2O2): Hydrogen peroxide is the most stable ROS. This 
is to say that it is the least reactive and the most readily detected. H2O2 may be 
generated directly by divalent reduction of O2 or indirectly by univalent reduction of 
O2•-. H2O2 is the primary product of the reduction of O2 by numerous oxidases, such as 
XO, uricase, D-amino acid oxidase and α-hydroxy acid oxidase localized in 
peroxisome. 
Hydroxyl radical (OH.): This is a highly reactive that reacts with practically 
any molecule present in cells thus making it a short-lived radical. This insufficient 
stability does not allow it to diffuse through the cells. Therefore, it reacts with an 
organic substrate at the sites or near the sites of its formation. The life span of OH. at 
37◦C is 10-9s. It does not survive for more than a few collisions after its formation. Due 
to such short lifetime, it is very difficult to investigate the OH. by conventional 
methods. This OH. is produced following the reaction of O2•- and H2O2 in presence of 
metallic ions such as Fe2+/Cu+. Lipid is very susceptible to OH. attack and initiate LPO. 
Because of interaction of OH. with DNA, formation of many types of oxidized 
nucleoside has been reported. 
1.9.2. Results of Oxidative Stress 
Lipid peroxidation: Polyunsaturated fatty acids (PUFA) of membrane are 
attacked repeatedly and severely by oxygen-derived free radicals to yield highly 
destructive PUFA radicals-lipid hydroperoxy radicals and lipid hypoperoxides. The 
lipid peroxidase is decomposed by transition metals such as iron causes lipid 
peroxidation is propagated the widespread membrane damaged and destruction of 
organelles. Malondialdehyde is the major reactive aldehyde resulting from the 
peroxidation of polyunsaturated fatty acid (PUFA)  present in the biological membrane. 
MDA, a secondary product of LPO, is used as an indicator of tissue damage by a series 
of chain reactions. MDA is also a by-product of prostaglandin biosynthesis. It reacts 
with thiobarbituric acid and produce red-colored products (Levine, 2002). 
Oxidation of protein: Oxygen-derived free radicals cause cell injury by 
oxidation of protein macromolecules of the cells, cross-linking of labile amino acids as 
well as by fragmentation of polypeptides directly. At the end, the result is degradation 
of cytosolic neutral proteases and cell destruction (Poljak et al., 2003). 
DNA damage: Free radicals cause breaks in the single strands of the nuclear 
and mitochondrial DNA. This result in cell injury; it may also cause malignant 
transformation of cells (Brennan et al., 1994). 
Cytoskeletal damage: Reactive oxygen species are also known to interact with 
cytoskeletal elements and interfere in mitochondrial aerobic phosphorylation and thus 
cause ATP depletion (Buettner & Schafer, 2000). 
1.9.3. Major Types of ROS Scavengers (Davies, 2000) 
Superoxide dismutase: SODs belong to family of metalloenzymes. SOD is the 
most important enzyme found virtually in all aerobic organisms. There are found 
families of SOD: Cu-SOD, Cu-Zn-SOD (cytosolic), Mn-SOD (mitochondrial) and Fe-
SOD. The transition metal of the enzyme reacts with O2•- taking its electron. O2•- is the 
only known substrate for SOD. SOD is considered a stress protein, synthesized in 
response to oxidative stress. SOD has been detected in a large number of tissues and 
organisms, and is thought that it is present to protect the cell from damage caused by 
O2•-. 
Catalase: CAT is an enzyme, which is present in most cells and catalyses the 
decomposition of hydrogen peroxide to water and oxygen. CAT is a heme containing 
protein. CAT is found to act 104 times faster than peroxidase. It is localized mainly in 
mitochondria and in sub cellular respiratory organelles. CAT is present in peroxisome 
(80%) and cytosol (20%). The decreased CAT activity may be because of higher ROMs 
production, especially O2•- itself affected directly the CAT activity. 
Glutathione: Glutathione plays a key role in the liver in detoxification 
reactions and in regulating the thiol/disulphide status of the cell. Oxidized glutathione 
(GSSG) can be enzymatically reduced by glutathione reductase and NADPH and 
simultaneously reduced glutathione (GSH) is oxidized to GSSG by glutathione 
peroxidase in the presence of H2O2. Oxidized glutathione, usually exists in very small 
concentrations in the liver cells (5% of total glutathione equivalents in liver). The 
maintenance of low GSSG concentration is accounted for its rapid reactions with 
protein thiols, its reduction by NADPH, glutathione reductase and its active transport 
out of the cells. Under conditions of oxidative stress associated with increased 
formation of GSSG, the concentration of GSSG does not increase significantly in liver. 
Thus, the mechanisms handling GSSG ensure that it does not accumulate.  
Glutathione S-transferases: GST’s are a group of detoxifying enzymes that 
catalyze the conjugation of reduced glutathione with a variety of compounds bearing 
suitable electrophilic centers in them. These enzymes are widely distributed in higher 
animals and are known to perform several detoxification functions. This group of 
enzymes is analogous to serum albumin in the broad spectrum of compounds that serve 
as ligands, but differs significantly in that the transferases have an additional and 
specific site for GSH. Examples of the reactions catalyzed include conjugation to the 
compounds with a reactive electrophilic carbon to form thioethers, reactions with other 
electrophilic atoms including the nitrogen of organic nitrates and the sulfur of organic 
thiocyanates; isomerisation; disulfide interchange; glutathione peroxidase activity with 
organic peroxides and formation of thiol-esters. 
1.10. N- Nitroso compounds: - 
 
N-nitroso compounds result from reactions involving chemicals called alkyl 
amines and these are formed by side-reactions when other products are made. EPA 
however has studied nitroso compounds and classified it as probable carcinogens. N-
nitroso compounds are highly toxic and carcinogenic. The characteristic toxic lesion 
produced by the nitrosamines is centrilobular necrosis of the liver, (Magee & Barnes, 
1967). The N-nitroso compounds include some of the most powerful known 
carcinogens, several being capable of producing tumors when given as a single dose in 
spite of their rapid elimination from the body. They are thus valuable agents for the 
study of mechanisms of the induction of cancer. Industry makes small amounts of N-
nitroso compounds for research purposes. 
 
1.10.1. Exposure to humans: 
 
Several ways of humans being exposed to nitroso compounds are listed below – 
• Eating: - foods containing these compounds include fish, cheeses, bacon, and 
other cured meats.  
• Breathing: - air containing these compounds near plants that use them, near a 
waste site containing N-nitroso compounds, or by breathing tobacco smoke or 
the air inside cars.  
• Drinking: - some alcoholic beverages; including beer and other malt beverages. 
Infants drinking from a rubber bottle nipple could possibly be exposed.  
• Touching: - these compounds if you work where they are used. Also by 
touching some cosmetics and toiletries, contain N-nitroso compounds.  
 
S.  No Nitroso compound Abbrev iation Chemical formu la
1 N-nitroso-diethylamine NDEA C 4 H 10 N 2 O
2 N-nitroso-dimethylamine NDMA C 8 H 10 N 2 O 
3 N-nitroso-di-n-butylamine NDBA C 8 H 18 N 2 O 
4 N-nitroso-di-n-propylamine NDPA C 6 H 14 N 2 O 
5 N-nitroso-methylethylamine NMEA C 2 H 6 N 2 O 
6 N-nitroso-pyrrolidine NPYR C 4 H 8 N 2 O  
Figure 6:- Few examples of N Nitroso compounds. 
1.10.2. N-nitroso-diethylamine 
 
Synonyms: -  
 
Diethylnitrosamine; diethylamine, N-nitroso; DEN; DENA; DANA. 
 
Structure:  
 
Physical properties: - 
 
Appearance  :  a yellow, volatile liquid 
Mol weight  :  102.1 
Solubility  :  10% in water; soluble in organic solvents and in 
lipids 
Boiling point  :  177°C (760 mm Hg) 64-65°C (17 mm Hg) 
Density  :  0.9422 (20/4°C) 
 
DEN has been shown to act as a carcinogenic to the mouse, the rat, the hamster, 
the guinea pig, the rabbit, the dog, the pig, the monkey, and to aquarium fish. 
Administration of DEN to animals produces cancer in liver and to other organs at a low 
incidence. The agent induces tumors primarily in the nasal cavity, trachea, esophagus, 
and liver. It causes cancer after different modes of exposure, which include ingestion, 
inhalation, and skin painting. It is carcinogenic in single doses and following prenatal 
exposure.  
 
DEN is metabolized to its active ethyl radical metabolite, and this reactive 
product interacts with DNA causing mutation, which leads to carcinogenesis, (Anis et 
al., 2001; Chakraborty et al., 2007). Hence, O4- ethyldeoxythymidine adduct (O4-Etdt) 
accumulates in hepatocyte DNA following DEN administration which is thought to be 
important in tumour initiation, (Dyroff MC, 1986). The involvement of free radicals in 
DEN-induced liver cancer has been extensively studied. 
Experimental, clinical, and epidemiological studies have provided evidences 
supporting the role of reactive oxygen species in the etiology of cancer. 
Diethylnitrosamine has been suggested to cause oxidative stress and cellular injury due 
to the enhanced formation of free radicals, (Ramakrishnan et al., 2006; Valko et al., 
2006). This was confirmed by over expression of 8-hydroxyguanine in DEN 
administered rat liver, (Nakae D, 1997). When the excess amount of ROS accumulates, 
numerous pathological effects may manifest in the cells including carcinogenesis (Dean 
RT, 1997). 
 
Continuous interaction of the animal with these free radicals causes damage of 
proteins, lipid, DNA, carbohydrates and membrane, resulting in oxidative stress. It is 
widely accepted metabolic activation of nitrosamines by cytochrome P450 enzymes to 
reactive electrophiles is required for their cytotoxic, mutagenic, and carcinogenic 
activity. Because of its relatively simple metabolic pathway and potent carcinogenicity, 
DEN has been used as an effective experimental model. The relationship between the 
involvement of free radicals and DEN activation was also demonstrated by induction of 
lipid peroxidation, which may be responsible for tumor formation (Bartsch H, 1989). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.11. Natural treatment against cancer: - 
 
A large number of agents including natural and synthetic compounds have been 
reported which have some chemo preventive value. Among these compounds, most are 
present in plants. Few phytochemicals that play an imperative role against class of 
diseases include the flavonoids (Hesperidin, Rutin, Quercetin, Nobeletin); phytosterols 
(Beta-sitosterol); phenolic acids (Capsaicin, Ellagic acid, Gallic acid); triterpenoids 
(Ursolic acid) etc. Flavonoids have found to have a chemo preventive role in cancer 
through the induction of enzymes affecting carcinogen metabolism and inhibit various 
activities of tumor promoters, which are involved in the process of carcinogenesis. 
Chemically, Flavonoids are polyphenolic compounds that are ubiquitous in nature and 
are grouped according to their chemical structure, into flavonols, flavones, flavanones, 
isoflavones, catechins, anthocyanidins, and chalcones. The position of hydroxyl groups 
and other features in the chemical structure of flavonoids are important for their 
antioxidant and free radical scavenging activities.  
 
They are present in fruits, vegetables, and beverages (tea, coffee, beer, wine, 
and fruit drinks). They possess strong antioxidant and radical scavenging activities. 
This makes flavonoids to act as antiviral, anti-allergic, antiplatelet, anti-inflammatory, 
anti-tumor agents. Few examples of well-known flavonols include quercetin, rutin, and 
hesperidin, while well-known flavones include apigenin and luteolin. Flavonoids in 
some cases may also be named directly after the unique plant that contains them. 
Ginkgetin is a flavonoid from the ginkgo tree, and tangeretin is a flavonoid from the 
tangerine.  
1.12. Hesperidin 
 
 Structure: - 
 
 
Synonyms: - Hesperetin 7-rhamnoglucoside, hesperetin-7-rutinoside, Hesperidoside; 
 
Molecular formula: - C28H34O15 
 
Molecular weight: - 610.57 
 
Hesperidin is one among over 4000 flavonoids found in plants and is the 
abundant and inexpensive by-product that comes from citrus fruits thus making it a 
naturally occurring citrus bioflavonoid also known as a phytochemical. Hesperidin was 
first isolated in 1828 from the albedo (the spongy inner portion of the peel) of oranges, 
and has since been found in lemons and other citrus fruits. It is found to be present 
mainly in the peel of the ordinary orange Citrus aurantium L., (Kanes et al., 1993; 
Emim et al., 1994), C. sinensis, (Horowitz and Gentili,1963), C. unshiu, (Kawaguchi et 
al., 1997) and other species of the genus Citrus (Family: Rutaceae).  
 
1.13.1. Properties: - 
 
Physical state: - White to yellow powder 
Melting point: - 257 – 262ºC 
Solubility in water: - Soluble 
pH: - 6.0 ~ 7.5 
Stability: - Stable under ordinary conditions, hygroscopic, light sensitive. 
1.13.2. Pharmacological Actions of hesperidin: - 
 
Both hesperidin and its aglycone hesperetin have been reported to possess a 
wide range of pharmacological properties. In a combination with others or alone, 
hesperidin is most often used for vascular conditions such as hemorrhoids and varicose 
veins. Hesperidin seems to work by improving venous tone, reducing stasis, restoring 
normal capillary permeability, and improving lymphatic drainage. 
 
 Hesperidin has been reported to possess anti hypercholesterolemic activity 
(Son et al., 199). Other than this it also possesses anti-inflammation, antioxidant, 
antifungal, anticarcinogenic, and analgesic effects, (Galati et al., 1994; Krolicki and 
Lamer-Zarawaska, 1984; Yang et al., 1997). The sugar causes hesperidin to be more 
soluble than hesperitin. The possible anti-cancer activity of hesperidin could be 
explained by the inhibition of polyamine synthesis. 
 
1.13.3. Pharmacokinetics of Hesperidin: - 
 
There is not much known about the pharmacokinetics of hesperidin in humans. 
It is unclear if hesperidin itself is absorbed from the intestine intact as a glycoside. The 
aglycone hesperetin is detected in the serum following ingestion and may be formed 
prior to or following absorption. Hesperetin may undergo glucuronidation in the wall of 
the intestine, as well as in the liver. Hesperetin is detected in the urine within three 
hours after ingestion of hesperidin. Urinary excretion appears to be the major route of 
excretion of the aglycone. Not much more is known about the metabolism of 
hesperidin. 
 
 
 
 
 
 
 
2. LITERATURE REVIEW 
 
Annida Balakrishnan et al., (2007). Hesperidin is a polyphenol, has been observed to 
possess antioxidant activity and also quenches free radicals. We thought that this 
compound may prevent the toxic effects of nicotine, which manifest its action through 
the generation of free radicals.  
Giuseppe Gattuso et al., (2007). Flavonoids are aromatic secondary plant metabolites, 
which have been recognized as important due to their physiological and 
pharmacological role and their health benefits. The amount of interest they have 
attracted is demonstrated by more than 13,000 articles and books dealing with various 
aspects of flavonoids chemistry, biochemistry, pharmaceutical and nutritional role 
which have appeared since 1990. Flavonoids show a strong antioxidant and radical 
scavenging activity and appear to be associated with reduced risk for certain chronic 
diseases, the prevention of some cardiovascular disorders, and certain kinds of 
cancerous processes. Flavonoids exhibit also antiviral, antimicrobial, and anti-
inflammatory activities, beneficial effects on capillary fragility, and an ability to inhibit 
human platelet aggregation, antiulcer and antiallergenic properties. 
Inge Lise F et al., (2006). Bioavailability of hesperidin was modulated by enzymatic 
conversion to hesperetin-7-glucoside, thus changing the absorption site from the colon 
to the small intestine. This may affect future interventions concerning the health 
benefits of citrus flavonoids. 
Balasubramanian Rajkapoor et al., (2005). N-Nitrosodiethylamine (DEN), one of the 
most important environmental carcinogens of this class, primarily induces liver tumor. 
It is widely accepted that metabolic activation of nitrosamines by cytochrome P450 
enzymes to reactive electrophiles is required for their cytotoxic, mutagenic and 
carcinogenic activity. Because of its relatively simple metabolic pathway and potent 
carcinogenicity, DEN has been used as an effective experimental model in the field of 
carcinogenesis and chemoprevention. 
Lin et al., (2002). Nitrate and nitrite are added to meat and fish for the purpose of 
preservation, as colour fixatives and as flavouring. Ingestion of nitrite and nitrate can 
result in the endogenous formation of nitroso compounds, particularly in the presence 
of nitrosatable precursors, such as primary amines, in the acidic condition of the 
stomach. 
Thirunavukkarasu C, et al., (2001). N-Nitrosodiethylamine (DEN) is a representative 
chemical of a family of carcinogenic N-nitroso compounds. Administration of DEN to 
animals has been shown to cause cancer in liver and at low incidence in other organs 
also. The involvement of free radicals in DEN-induced liver cancer has been 
extensively studied. 
Pattanayak D et al., (1999). Continuous interaction of the animal with these free 
radicals causes damage of proteins, lipid, DNA, carbohydrates and membrane, resulting 
in oxidative stress. In order to maintain cellular health, it is essential to have a specific 
and effective chemical scavenger to target multiple types of radicals. Most of the 
commercially based antioxidant supplements are single oxidant. 
Hecht SS., (1997). In addition, exposure of man to preformed nitrosamines occurs due 
to the use of tobacco products, cosmetics, pharmaceutical products and agricultural 
chemicals. 
Cho KJ et al., (1993). The chronic CCl4 administration produced complete or 
incomplete liver cirrhosis and exerted a strong promoting effect on the development of 
neoplastic nodules. Ethanol alone revealed no cirrhogenous or tumor-promoting effect, 
but enhanced both actions of CCl4. Acetaldehyde increased only the cirrhogenous 
effect of CCl4. 
Beckman JS et al., (1990). Generally, oxygen free radicals are natural physiological 
products, but also extremely reactive oxygen species (ROS). They have been proved to 
cause numerous cellular anomalies, including but not limited to protein damage, 
deactivation of enzymatic activity, alteration of DNA and lipid peroxidation of 
membranes. 
Dyroff MC et al., (1986). Initiation during or after DEN exposure is thought to be a 
rapid metabolism of DEN to reactive metabolites that interact with DNA, forming 
various DNA adducts that can lead to mutations. Hence, O4- ethyldeoxythymidine 
adduct (O4-Etdt) accumulates in hepatocytes DNA following DEN administration 
which is thought to be important in tumour initiation. 
 
3. AIM AND SCOPE OF STUDY 
 
Cancer or malignant neoplasm as it is termed is a class of diseases where a 
group of cells displays uncontrolled growth, invasion, and sometimes metastasis. 
Cancer is found to be responsible for partial or complete breakdown of the control 
mechanisms of cellular proliferation, including cell cycle regulatory proteins. Causing 
about 13% of all deaths worldwide it has gained itself massive importance thus making 
it a challenging area of research. In our study, liver was mainly concentrated being one 
of the deadly types of cancers. It has been reported that hepatocellular carcinoma alone 
causes 653,000 deaths worldwide per year, about half of them in China. 
Hepatocarcinogenesis is a multistage process, normally resulting in a highly malignant 
tumour; however, progressive growth of hepatocytes from their normal state to 
malignancy is not clear yet. 
Several carcinogens can produce liver toxicity by initiating an abnormal 
process, which is followed by regeneration, growth, and clonal proliferation, eventually 
leading to cancer. Until today, several studies have been performed on cancer, its 
prevention; or its treatment; but the cause of many cancers are still unknown. Though 
numerous carcinogens are present, administration of nitrosamines to rats has proved to 
cause high incidence cancer in the liver and at low incidence in the other organs. 
 Nitrosamines are widely recognized as carcinogenic compounds but it requires 
microsomal activation before it can exert their cytotoxic and carcinogenic activity. 
DEN has been proved to be one of the effective agents to cause oxidative stress and 
cellular injury which is due to the enhanced formation of free radicals. It has been 
reported that DEN is present in tobacco and various processed foods, foodstuffs, such 
as milk and meat products, salted fish and alcoholic beverages and is formed in vivo in 
physiological conditions primarily inducing tumors of liver. 
  DEN being an oxidant can utilize several different avenues to alter cellular 
function including signal transduction pathways and expression of genes relevant to 
generation of mitogenic signals to the oxidant resistant carcinogen-initiated cells 
causing tumor promotion, apart from initiating a toxicity signal to normal cells. Reports 
suggest that the mechanism by which DEN produces its activity is by the oxidation of 
the α-carbon by the cytochrome P450 monooxidase system to form unstable, 
intermediate, DEN radical and reactive oxygen species, which readily reacts with the 
DNA to form alkyl-DNA adduct or so called tumor promoters. This tumor promoter 
appears to induce a super oxide anion, which leads to the formation and thus the 
accumulation of super oxide and hydrogen peroxide in the cell. This exposure of DNA 
to super oxide-generating systems causes formation of reactive hydroxyl radical 
thereby causing extensive strand breakage and degradation of deoxyribose. This results 
in increased LPO, thus increasing membrane damage the extent of which is measured 
by the increased levels of MDA. Reports also proved that DEN induction led to 
increase in the liver markers (AST, ALP, and ALT) as well as the antioxidant enzymes 
(SOD, CAT, GPx, GR and GSH) which are helpful in knowing the extent of 
carcinoma. 
Hesperidin (HDN) is a flavanone glycoside abundantly found in sweet orange 
and lemon and is an inexpensive by-product of citrus cultivation. Several studies prove 
that abnormal capillary leakiness as well as pain in the extremities causing aches, 
weakness, and night leg cramps. It has also been reported to possess significant anti-
inflammatory, analgesic, antifungal, and antiviral activities. A number of studies have 
examined the antioxidant, anticancer activity, and free radical scavenging properties of 
hesperidin. Since Hesperidin has been proved to have antioxidant effect, an attempt to 
check the extent of free radicals scavenging activity over DEN induced conditions was 
made in our studies. To check this, significant changes that occurred in liver marker 
enzymes (AST, ALP, and ALT) along with serum bilirubin and antioxidant enzymes 
(SOD, CAT, GPx, GR and GSH) were studied under DEN induced and Hesperidin 
treated conditions. Several assay studies have been developed to examine the 
antioxidant activity and free radical scavenging activity of Hesperidin. 
 
 
 
 
4. PLAN OF WORK 
4.1. Estimation of liver marker enzymes 
¾ Assay of Aspartate transaminase, (AST) 
¾ Assay of Alanine transaminase, (ALT) 
¾ Assay of Alkaline phosphatase, (ALP) 
4.2. Determination of Lipid peroxides in Liver 
4.3. Estimation of antioxidant status 
¾ Assay of Superoxide dismutase (SOD) 
¾ Assay of Catalase (CAT) 
¾ Assay of Glutathione peroxidase (GPx) 
¾ Assay of Glutathione reductase (GR) 
¾ Assay of Glutathione (GSH) 
4.4. Assay of Tumor Necrosis Factor - alpha (TNF-α) 
4.5. Histopathological studies 
4.6. Statistical Analysis 
 
 
 
 
 
5. MATERIALS AND METHODS 
5.1. ANIMAL MODEL 
The study was conducted using Male albino Wistar rats (150 ± 10gms). 
Animals were obtained from the animal house, Vel’s College of Pharmacy; The 
Tamilnadu Dr MGR Medical University, Chennai, India. The animals were fed with 
commercially available standard rat pellet feed from M/s Hindustan Lever Ltd; 
Bangalore, India. The feed and water were provided ad libitum. The animals were 
deprived of food for 24 hr before experimentation but allowed free access to tap water 
through out. The rats were housed under conditions of controlled temperature (25 ± 
2OC) and were acclimatized to 12-h light: and 12-h dark cycles. Experimental animals 
were used after obtaining prior permission and handled according to the Institutional 
Animal Ethical Committee (IAEC) of Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), Ministry of Social Justice and 
Empowerment; Government of India. 
 
5.2. EXPERIMENTAL PROTOCOL: - 
 
Group I: Normal control rats were supplied with sufficient amount of food and  
         water. 
 
Group II: Rats were given hesperidin orally (100mg/kg/day) for 14 weeks. 
 
Group III: Rats were given a single intraperitoneal injection of DEN (200mg/kg).  
           After 1 week, the rats were given PB (0.05% in drinking water) for 13  
           weeks. 
 
Group IV: Rats were given hesperidin one week prior to the injection of DEN. The  
           oral administration was then continued throughout the experimental  
           period (14 weeks) along with the administration of PB. 
 
 After the end of experimental period, all the animals were anesthetized and 
decapitated. Liver tissues were immediately excised and rinsed in ice-cold 
physiological saline. The tissues were homogenized in 0.01 M Tris-HCl buffer (pH 7.4) 
and aliquots of this homogenate were used for the assays. Blood was collected and 
serum was separated for analysis of biochemical parameters. 
5.3. BIOCHEMICAL ESTIMATIONS: - 
5.3.1. Estimation of Liver Marker Enzymes 
5.3.1.1. Assay of Aspartate transaminase, (AST) 
 The method of Reitman and Frankel (1957) was adopted for the assay of 
aspartate transaminase. 
Reagents: 
Phosphate buffer :  0.1 M, pH 7.4 
Sodium hydroxide :  0.4 N solution 
Substrate:  2.66 g of DL-aspartate and 38 mg of α-oxaloglutarate were 
dissolved in 20.5 ml of 1 N NaOH with gentle heating. This was made 
up to 100 ml with buffer. 
DNPH   :   1 mM 2, 4-dinitrophenyl hydrazine in 2 N HCl. 
Standard pyruvate  :  10 mg of sodium pyruvate was dissolved in 100 
ml of phosphate buffer 0.1 M, pH 7.4. 
Procedure 
 In different tubes, 1.0 ml of buffered substrate was added to 0.1 ml of serum 
or 0.1 ml of enzyme source and incubated at 37°C for 1 hour. Then 1.0 ml of DNPH 
reagent was added to arrest the reaction. To the blank tubes, 0.1 ml of distilled water 
was added instead of serum. The tubes were kept aside for 15 minutes. Then 10 ml of 
0.4N sodium hydroxide was added and read at 520 nm in a Shimadzu UV 
spectrophotometer. 
 The enzyme activity was expressed as IU/l for serum. 
5.3.1.2. Assay of Alanine transaminase, (ALT) 
 The Reitman and Frankel (1957) methodology was adopted for the assay of 
alanine transaminase too. 
 The reagents and method used were the same as those used for the assay of 
aspartate transaminase except for the substrate solution and the incubation time was 
reduced to 30 minutes. 
Substrate 
 1.78 g of DL-Alanine and 38 mg of α-oxaloglutarate were dissolved in 
buffer. 0.5 ml of sodium hydroxide was added and the volume was made up to 100 ml 
with buffer.  
 The enzyme activity was expressed as IU/l for serum. 
Assay of Alkaline phosphatase, (ALP) 
 Alkaline phosphatase was assayed by the method of Kind and King (1954). 
Reagents 
1. Carbonate - bicarbonate buffer : 0.1 M, pH 10.0 
2. Disodium phenyl phosphate solution : 0.01 M 
3. Magnesium chloride solution  : 0.1 M 
4. Sodium carbonate solution  : 15% 
5. Folin's phenol reagent   : Commercial reagent,  
       1:2 dilution 
6. Standard phenol: 100 mg of recrystallized phenol in 100 ml of water 
was prepared. 100 µg of phenol per ml was then prepared by proper 
dilution and used as the working standard. 
Procedure 
 The reaction mixture of 3.0 ml containing 1.5 ml of buffer, 1.0 ml of 
substrate and requisite amount of the enzyme source was incubated at 37°C for 15 
minutes. The reaction was arrested by the addition of 1.0 ml of Folin's phenol reagent. 
The control tubes received the enzyme after arresting the reaction. The contents were 
centrifuged and to the supernatant, 1.0 ml of 15% sodium carbonate solution, 1 ml of 
substrate and 0.1 ml of magnesium chloride were added and the mixture was incubated 
for 10 minutes at 37°C. The colour was read at 640 nm against a blank in a Shimadzu 
UV spectrophotometer. The standard solution of phenol of varying concentrations was 
also treated similarly. 
 The enzyme activity was expressed as IU/l for serum. 
Determination of Lipid Peroxides in Liver 
 The levels of lipid peroxides were determined by ‘Thio barbituric acid’ 
reaction as described by Ohkawa et al. (1979). 
Reagents 
1. Sodium dodecyl sulphate (SDS) : 8.1% 
2. Acetic acid : 20%, pH 3.5 
3. Thiobarbituric acid (TBA) : 0.8% 
4. n-butanol/pyridine mixture  : 15:1 (v/v) 
5. 1,1′,3,3′-tetramethoxypropane 
Procedure 
 To 0.2 ml of homogenate, 0.2 ml of SDS, 1.5 ml of acetic acid and  
1.5 ml of TBA were added. The mixture was made upto 4 ml with water and then 
heated in a water bath at 95°C for 60 minutes using glass ball as a condenser. After 
cooling, 1 ml of water and 5 ml of n-butanol/pyridine mixture were added and shaken 
vigorously. After cetrifugation at 4,000 rpm for 10 minutes, the organic layer was taken 
and its absorbance at 532 nm was measured. 1,1′,3,3′-tetramethoxypropane was used as 
standard. 
 Tissue lipid peroxide levels were expressed as n moles of MDA/mg protein. 
Estimation of Antioxidant Status 
5.3.3.1. Assay of Superoxide dismutase, (SOD)  
 Superoxide dismutase was assayed following the method of Misra and 
Fridovich (1972). 
Reagents 
1. Carbonate bicarbonate buffer : 0.1 M, pH 10.2 
2. EDTA solution : 0.6 mM 
3. Epinephrine : 1.3 mM (prepared freshly) 
4. Absolute ethanol 
5. Chloroform 
Procedure 
 0.1 ml of enzyme source was added to tubes containing 0.75 ml of ethanol 
and 0.15 ml of chloroform (chilled in ice) and centrifuged. To 0.5 ml of supernatant, 
added 0.5 ml of EDTA solution and 1 ml of buffer. The reaction was initiated by the 
addition of 0.5 ml of epinephrine and the increase in absorbance at 480 nm was 
measured in a Shimadzu UV spectrophotometer. 
 The enzyme activity was expressed as units/min/100 mg protein. One unit 
of SOD activity is the amount of protein required to give 50% inhibition of epinephrine 
auto oxidation.  
5.3.3.2. Assay of Catalase, (CAT) 
 Catalase was assayed according to the method of Beers and Sizer (1952). 
Reagents 
1. Phosphate buffer : 50 mM, pH 7.0 
2. Hydrogen peroxide : 30 mM in phosphate buffer 
Procedure 
 To 1.2 ml of phosphate buffer, 0.1 ml of tissue homogenate was added. The 
enzyme reaction was started by the addition of 1.0 ml of hydrogen peroxide solution. 
The decrease in absorbance was measured at 240 nm for 3 minutes in a Shimadzu UV 
spectrophotometer. The enzyme blank was run simultaneously with 1.0 ml of distilled 
water instead of hydrogen peroxide. 
 The enzyme activity was expressed as µmoles of H2O2 decomposed/min/mg 
protein. 
5.3.3.3. Assay of Glutathione peroxidase, (GPx) 
 The activity of glutathione peroxidase was assayed by the method of 
Rotruck et al. (1973). 
Reagents 
1. Phosphate buffer : 0.4M,  pH 7.0 
2. EDTA : 0.8 mM 
3. Sodium azide  : 10 mM 
4. Reduced glutathione  : 4 mM 
5. H2O2  : 2.5 mM 
6. TCA : 10% 
7. Disodium hydrogen phosphate : 0.3M 
8. DTNB solution  : 40 mg of DTNB in 100 ml of  
  1% sodium citrate 
9. Standard reduced glutathione 
Procedure 
 The reaction mixture consisted of 0.2 ml of EDTA, 0.1 ml of sodium azide, 0.1 
ml of H2O2, 0.2 ml of reduced glutathione, 0.4 ml of phosphate buffer and 0.2 ml 
homogenate was incubated at 37°C for 10 minutes. The reaction was arrested by the 
addition of 0.5 ml of TCA and the tubes were centrifuged at 2,000 rpm. To the 
supernatant, 3 ml of disodium hydrogen phosphate and 1.0 ml DTNB were added and 
the colour developed was read at 420 nm immediately in a Shimadzu UV spectrometer. 
The enzyme activity was expressed as n moles of glutathione oxidized/min/mg protein. 
5.3.3.4. Estimation of Glutathione Reductase (GR)  
The activity of glutathione peroxidase was assayed by the method of (Smith et 
al., 1988) 
Reagents 
1. 5, 5’-dithiobis (2-nitrobenzoic acid) 
2. NADPH 
Procedure 
GR activity was measured by monitoring the rate of production of 5-thio-2-
nitrobenzoic acid (TNB) from 5, 5’-dithiobis (2-nitrobenzoic acid) (DTNB) at 412 nm, 
which is coupled with the GR reaction, as described previously. Homogenates (5%) 
were centrifuged 10 min at 8400 3 g; assays were performed on crude supernatants as 
described, except that no glutathione disulfide was added to the reaction mixture. The 
blank with no NADPH in the mixture was subtracted from the rate with 0.1 mM 
NADPH (final concentration) for each sample. Activity was calculated using an 
extinction coefficient of 13,600 M21 cm21, based on the change in absorbance at 
412nm for 2.0–4.8 min after simultaneous mixing of control and experimental samples 
and blanks. 
The enzyme activity was expressed as nmole TNB formed mg-1protein min-1. 
5.3.3.5. Estimation of Glutathione (GSH) 
 The level of total reduced glutathione in the liver tissue was measured by 
the method of Moron et al. (1979). 
Reagents 
1. Phosphate buffer : 0.2 M, pH 8.0 
2. DTNB  : 0.6 mM in 0.2 M phosphate buffer, pH 8.0 
3. TCA : 10% 
Procedure 
 1.5 ml of liver homogenate was precipitated with 1 ml TCA. The contents 
were mixed well for complete precipitation of proteins and centrifuged. To 0.5 ml of 
clear supernatant, 2.0 ml DTNB was added and the total volume was made upto 3 ml 
with phosphate buffer. The absorbance was read at 412 nm against a blank containing 
TCA instead of sample. A series of standards treated in a similar way were also run to 
determine the glutathione content. 
 The amount of glutathione was expressed as n moles/g wet tissue. 
Assay of Tumour Necrosis Factor – α, (TNF-α) 
 The level of TNF-α was measured by using enzyme linked immunosorbent 
assay as described earlier in section 2.26.6 using mouse monoclonal antibody against 
rat TNF-α (1:5000 dilution) and Goat-antimouse IgG-HRP conjugate. 
 The level of TNF-α was expressed as ng/mg protein using a calibration 
curve obtained from standard TNF-α. 
HISTOPATHOLOGICAL STUDIES 
 Small pieces of liver tissues were collected in 10% formal saline for proper 
fixation. These tissues were processed, embedded in paraffin wax sections of 5-6 µm 
thick, cut and stained with hematoxylin and eosin (Luna, 1966). The sections were 
examined under light microscope and photomicrographs were obtained. 
 
 
STATISTICAL ANALYSIS 
 All the grouped data were statistically evaluated with Statistical Package for 
Social Sciences (SPSS), Version 7.5.  Hypothesis testing methods included one way 
analysis of variance (ANOVA) followed by least significant difference (LSD) test. A 
‘P’ value of less than 0.05 was considered to indicate statistical significance. All the 
results were expressed as mean + S.D. for six animals in each group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. RESULTS 
¾ Effect of HESP on DEN-induced alteration in body weight, liver weight and 
relative liver weight  
Table-1 represents the liver weights of DEN induced rats (Group III) 
significantly (p < 0.05) increases as compared to that of the control rats. Treatment with 
hesperidin (Group IV) however showed that weights are significantly (p < 0.05) 
restored as compared to rat of group III. This reduction showed that the liver relative 
weights are lowered near to normalization as in group II rats. 
¾ Effect of Hesperidin on the levels of diagnostic liver marker enzymes: 
 In the present study, intraperitoneal administration of a single dose of DEN 
(200mg/kg body weight) induced severe biochemical changes as well as oxidative 
damage in hepatic tissues. There was a significant (p < 0.05) rise in the level of 
diagnostic marker enzymes (AST, ALT and ALP) in the serum of Group III DEN 
administered rats as compared to that of Group I control rats (Table 1). The 
administration of hesperidin restored the levels of these enzymes to near normalcy (p < 
0.05) as compared to those group III DEN injected rats. In hesperidin alone 
administered rat’s Group II vs. control, no significant changes were observed. 
 
¾ Effect of Hesperidin on the levels of GSH and MDA in hepatic tissue 
 Injection of DEN induced a significant (p < 0.05) increase in the level of 
lipid peroxidation measured in terms of MDA (Figure-7) which was paralleled by 
significant (p < 0.05) reduction in the level of GSH in the liver tissue of Group III 
animals as compared to normal controls(Table 4). In this study the treatment with 
hesperidin group IV significantly counteracted the DEN induced LPO and restored the 
level of GSH to near normal level in group IV rats as compared to that of group III 
animals. 
¾ Effect of Hesperidin on the level of hepatic tissue antioxidants 
 Activities of glutathione dependent antioxidant enzymes (GPx, and GR) and 
antiperoxidative enzymes (SOD and CAT) was significantly lower in liver tissue of 
Group III DEN injected rats as compared to that of Group I normal control rats(Table 
3). The observed reduction in the activities of GPx, and GR in DEN induced hepatic 
damage might be due to decreased availability of its substrate, reduced GSH. In the 
present study in the treatment of group IV rats of DEN with hesperidin significantly 
reversed all these DEN induced alteration in the activities of antioxidant enzymes 
(SOD, CAT, GPx, and GR) to a near normal status. The normal rats receiving alone 
hesperidin did not show any significant change when compared with control rats 
indicating that it does not per se have any adverse effects. 
 
¾ Effect of Hesperidin on the levels of serum TNF-α  
Figure-9 illustrates the serum levels of TNF-α respectively. There was a significant 
(p < 0.05) rise in the levels of TNF-α in the serum of DEN intoxicated rats (Group III) 
as compared to that of control rats (Group I). The administration of hesperidin to Group 
IV animals restored the levels of TNF-α to near normalcy (p < 0.05). 
 
¾ Effect of   HESP on DEN-induced alteration in body weight, liver weight 
and relative liver weight in control and experimental rats 
 
MORPHOLOGICAL STUDIES 
 A. CONTROL 
            Normal untreated rat liver. 
 
             B. HESPERIDIN ALONE 
Section shows normal cellular architecture 
 
             C. DIETHYLNITROSAMINE TREATED 
Section shows area of aberrant hepatocellular phenotype with variation 
in nuclear size, hyperchromatism, and irregular sinusoids (400×);   
 
             D. HESPERIDIN + DIETHYLNITROSAMINETREATED 
Section shows hepatocytes maintaining near-normal architecture.  
 
 
HISTOPATHOLOGICAL STUDIES 
The livers of normal animals (Group I) and HESP alone treated (Group II) 
revealed normal parenchymal cells with granulated cytoplasm and small uniform nuclei  
arranged (Figure-10, 11). Animals subjected to DEN regimen alone showed a loss of 
normal architecture with oval- or irregular-shaped hepatocytes (Figure-12). The 
transformed liver cells of foci and nodules were substantially enlarged, largely 
vesiculated and frequently binucleated, which were clearly distinguishable from the 
surrounding normal parenchyma. The nuclei were mostly found to be pleomorphic with 
fine granular chromatin and occasionally with small nucleoli. Several nuclei were large 
hyperchromatic (basophilic) with prominent and centrally located nucleoli. 
Additionally, extensive vacuolation was noticed in the cytoplasm encircling the nucleus 
with masses of acidophilic (eosinophilic) material. The cellular architecture of liver 
sections in rats that received HESP (100 mg/kg) + DEN (Group IV) seemed to be 
normal counterparts (Figure-13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. DISCUSSION 
 
Diethylnitrosamine chemically belonging to the N-Nitrosamine family is proved 
to be one of the potent carcinogens that produced hepatotoxicity in around 30 species of 
animals. DEN is primarily metabolized by the cytochrome P-450 enzymes to reactive 
electrophiles (O6 alkyl-guanine and N7 alkyl-guanine) which are proved to be 
cytotoxic, carcinogenic and mutagenic (Archer MC, 1989; Swann PF and Magee PN, 
1971). As proved, DEN grounds for producing oxidative stress by causing a redox 
imbalance between the production of ROS and its detoxification by the cellular 
enzymes, (James E et al; 1998). DEN through normal or futile mechanisms causes 
production of ROS, and continuous or excessive exposure of ROS on the cells causes 
DNA damage; oxidations of amino acids in  proteins and polyunsaturated fatty acids in 
lipids; as well as oxidative inactivation of the specific cellular enzymes, thereby 
causing OS, (Ramakrishnan G et al; 2006; Dean RT et al; 1997). 
 
Oxidative damage of DNA is however proved to exhibit long term effects, 
(Evans MD et al; 2004). Thus it becomes evident to select a scavenger that would 
reduce the ROS production, both evidently and effectively. Several evidences proved 
that induction of DEN leads to increased levels of LPO products, diagnostic liver 
marker enzymes (AST, ALP, and ALT) and bilirubin in serum and significantly 
decreased the levels of antioxidants (SOD, CAT, GPx, GR and GSH) proteins and  uric 
acid, (Kumar RS et al; 2007). The restorative effect of hesperidin on the altered levels 
of LPO, liver markers, and antioxidants were reported in the study.  
 
Polyunsaturated lipids (PUFA) in the hepatocellular membrane are deteriorated 
by the reaction of oxygen with the membrane lipids directly to form free radical 
intermediates and semi stable peroxides. This reaction referred to as LPO, causes 
damage to the structural integrity of the cell membrane, (Rice-Evans C and Burdon R, 
1993). On administration of DEN, a significant elevation on the amount of 
malondialdehyde (MDA); considered to be the end product of LPO was observed 
which indicates increased levels of LPO, (Thirunavukkarasu C and Sakthisekaran D, 
2001). This increase leads to failure of the antioxidant defense mechanism thereby 
causing tissue damage. Treating the rats with hesperidin however proved to modulate 
the increased LPO level which is in consistent with the previous reports, (Balakrishnan 
A and Menon VP, 2007). 
 
The serum levels of marker enzymes provide more information about the type 
and extent of hepatocellular damage. The levels of AST, ALT, ALP, and bilirubin in 
the serum were studied for the diagnosis of hepatic damage. This is because these are 
cytoplasmic enzymes and are released into circulation following cellular damage, 
(Ansari RA et al; 1991). The activities of marker enzymes in serum increased 
significantly following DEN induction, thus causing damage to the structural integrity 
of the cell membrane, (Pradeep K et al; 2007). Several evidences proved that treating 
the rats with hesperidin in a dose dependent manner reduced the level of the serum 
marker enzymes, thereby reducing the incidence of hepatotoxicity, (Pradeep K et al; 
2008). 
 
GSH a major tripeptide is a non enzymatic biological antioxidant mainly 
responsible for the regulation of cell functioning and protection against oxidative 
injury. Its levels are reduced automatically when the levels of LPO is increased which 
is because in increased LPO conditions there is more consumption of GSH, 
(Shanmugarajan TS et al; 2008). As reported that DEN induction causes the increase in 
levels of LPO and the GSH levels are declined significantly. The depletion of GSH in 
DEN induced rats leads to more exposure of oxidative stress on the cell, (Rajasekaran 
NS et al; 2002). However, hesperidin administration ameliorated the increased levels of 
GSH levels as compared to the levels of DEN intoxicated rats, (Kaur G et al; 2006).  
 
SOD, CAT, GPx and GR are important anti per oxidative enzymes which 
effectively scavenge the superoxide and hydrogen peroxide levels, (Gupta M et al; 
2003). These enzymes are responsible for the protection against oxidative damage. It 
has been strongly reported that the administration of DEN significantly lowered the 
enzymatic antioxidant defense mechanism which is attributed to the oxidative stress in 
liver, (Pradeep K et al; 2007). SOD is responsible for the dismutation of superoxide 
anions to hydrogen peroxide (Oberlay LW, 1979) and CAT decomposes the hydrogen 
peroxide to hydroxyl radicals (Chance B, 1952). These enzymes play a sequential 
antioxidant defense against the several oxidative stress models. In our present 
investigation the significant decrease in the levels of SOD and CAT were observed due 
to the increase in the levels of superoxide anions thus, more consumption of SOD and 
the utilization of CAT in removal of H2O2 during DEN exposure. Apart from SOD and 
CAT, GPx is another important glutathione dependent antioxidant enzyme that is 
responsible for scavenging the H2O2 and hydroperoxide radicals (Gaetani GF, 1989; 
Huang Z, 2001). It has been suggested that the depletion of GSH causes decrease in 
glutathione dependent antioxidant enzyme levels in DEN provoked oxidative damage 
which is in line with the previous studies. Several studies suggested that the flavonoids 
possess potent antioxidant and free radical scavenging activity. Treatment with 
hesperidin thus restores the levels of the antioxidant enzymes and protects the 
hepatocytes against the DEN induced oxidative stress in rat liver which may be due to 
the several pharmacological activities taking place. 
 
Mounting evidences also recommend that other than ROS generation, DEN is 
also involved in producing inflammatory responses. It has been suggested that DEN 
stimulates macrophages & neutrophils (Mitsuru Matsuda1 et al; 2005) which leads to 
release of certain pro-inflammatory cytokines such as the TNF-α which play an 
important role in amplification loop of immune responses, (Chia-Chou Yeh, 2007). In 
our study, administration of DEN increases the production of the circulating TNF-α. 
Hesperidin however has been strongly proved to suppress the expression of the TNF-α 
levels thereby behaving as a protective agent against the DEN. 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
 The present study is an effort to evaluate the protective efficacy of Hesperidin 
by studying the morphological and biological alteration observed in DEN induced 
hepatocelular carcinoma in rats. The outcome of the investigation carried out was 
summarized below.  
 The liver weight and relative liver weight were found to be increased in DEN 
induced rats and restored upon treatment with the hesperidin indicates its protective 
effect. 
 The activities of serum marker enzymes namely AST, ALT, ALP were found to 
be elevated within rats induced with DEN. Hesperidin treatment against DEN brought 
back the activities of marker enzymes to to near normal by protecting the cell 
membrane integrity. 
 An enhancement in lipid peroxide levels with simultaneous depression in the 
levels of antioxidants was observed in rats induced with DEN. Hesperidin treatment 
exerted a significant free radical quenching and antioxidant strengthening effects by 
decreasing the lipid peroxidation with consequent improvement in antioxidant status 
proving to be a potent antioxidant. 
 Histopathological observations in DEN induced and hesperidin treated rats 
revealed the protective nature of the extract against DEN induced hepatocellular 
carcinoma and further support the hepatoprotective potential of hesperidin.  
 Administration of DEN in rats resulted in increased levels of TNF-α. These 
elevated levels of TNF- α were inhibited and normal levels were attained by treatment 
with hesperidin.  
 The present findings explore that treatment shows promising protective effect of 
hesperidin and further studies are needed to understand the molecular mechanisms of 
the hesperidin against DEN induced liver cancer. Hence it is concluded that hesperidin 
as potential for further development as a therapeutic agent for liver cancer. 
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TABLE-1:  Effect of HESP on DEN induced alteration in body weight, liver weight and 
                   relative liver weight in control and experimental rats. 
 
Parameters Group-I (Control) 
Group-II 
(HESP) 
Group-III 
(DEN) 
Group-IV 
(HESP+DEN) 
INITIAL BODY 
WEIGHT 163.16  ±.8.18 172.86±11.39
 NS 176.83±7.38*a 174.16±8.01*b 
FINAL BODY 
WEIGHT 274.50±8.66 269.50±16.4
 NS 211.33±13.26*a 264.16±15.62*b 
 
LIVER WEIGHT 
 
7.63 ± 0.44 7.45±0.76 NS 13.16±0.81*a 8.21±0.61*b 
RELATIVE 
WEIGHT 2.77±0.08 2.75±0.11
 NS 6.23±0.38*a 3.10±0.12*b 
 
Values are expressed as mean ± S.D. for six animals. Body weight and liver weight Unit: gm.   
a=Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
  
 
 
TABLE-2:  Effect of HESP on DEN induced liver marker enzymes in serum of control  
                     and experimental rats. 
 
Parameters Group-I (Control) 
Group-II 
(HESP) 
Group-III 
(DEN) 
Group-IV 
(HESP+DEN) 
AST 115.88±5.16 115.70±5.16 NS 365.52±12.10*a  256.25±10.15*b 
 
ALT 
 
42.04±1.28 42.56±1.25 NS 141.32±5.45*a  96.21±3.10*b 
ALP 58.92±2.42 60.69±2.97 NS 134.48±4.24 *a 84.70±2.35*b 
 
Values are expressed as mean ± S.D. for six animals. Liver marker enzymes unit: IU L-1 (AST, ALT and 
ALP). 
 a= Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS= represents  non significance at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
TABLE-3: Effect of HESP on DEN induced MDA and GSH level in liver of control  
                    and experimental rats. 
 
Parameters Group-I (Control) 
Group-II 
(HESP) 
Group-III 
(DEN) 
Group-IV 
(HESP=DEN) 
 
LPO 
 
1.83±0.08 1.79±0.07 NS 5.11±0.53*a 2.79±0.28*b 
GSH 51.33±4.24 51.26±3.40 NS 14.91±1.69*a 35.85±3.41*b 
 
Values are expressed as mean ± S.D. for six animals. Units: MDA (n mole mg-1 protein); and GSH (mg dL-1). 
a= Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table-4: Effect of HESP on DEN induced antioxidant enzymes in liver of control and 
     experimental rats. 
 
Parameters Group-I (Control) 
Group-II 
(HESP) 
Group-III 
(DEN) 
Group-IV 
(HESP=DEN) 
SOD 7.93±0.69 8.01±0.55 NS 4.03±0.27 *a 6.80±0.69*b 
 
CAT 
 
69.34±4.65 68.89±3.67 NS 43.07±3.36 *a 58.37±3.48*b 
GPX 116.85±5.28 117.73±5.74 NS 67.52±4.79 *a 89.55±7.82*b 
GR 192.55±18.23 195.32±17.66 NS 102.31±8.07*a 151.04±7.75*b 
 
Values are expressed as mean ± S.D. for six animals. Units: SOD (Units min-1mg-1 protein); CAT (µmole H2O2 
consumed min-1mg-1 protein); GPx (µmole of GSH oxidized min-1mg-1 protein); and GR (nmole g-1 tissue).  
a= Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table-5: Effect of HESP on DEN induced TNF-α level in serum of control and  
                experimental rats 
Parameters Group-I (Control) 
Group-II 
(HESP) 
Group-III 
(DEN) 
Group-IV 
(HESP+DEN) 
TNF-α 8.49 ±.1.40 8.87±1.12NS 18.96±1.37*a 13.69±1.56*b 
 
Values are expressed as mean ± S.D. for six animals. Units: TNF-α (ng/mg protein). 
a= Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV.  
The * represent the statistical significance at p < 0.05. 
NS = represents non significance at p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure-7: Effect of HESP on DEN induced LPO in liver of control and experimental rats 
 
Values are expressed as mean ± S.D. for six animals. Units: MDA (n mole mg-1 protein); 
a=Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
 
 
 
  
 
 
Figure-8: Effect of HESP on DEN induced GSH in liver of control and experimental rats 
 
 
Values are expressed as mean ± S.D. for six animals. Units: GSH mg dL-1.  
a=Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
 
 
  
 
 
Figure-9: Effect of HESP on DEN induced TNF-α in liver of control and experimental rats 
 
 
Values are expressed as mean ± S.D. for six animals. Units: TNF-α (ng/mg protein). 
a=Comparisons are made between Group-I with Group-III. 
b= Comparisons are made between Group-III with Group IV. 
The * represent the statistical significance at p < 0.05. 
NS represents non significance at p < 0.05. 
 
 
 
 
 
 
 
  
HISTOPATHOLOGICAL EXAMINATION 
 
 
 
 
 
 
 
 
 
        Figure 10 - (Group-I) Control rat (400x)   Figure 11 - (Group-II) HESP treated rat (400x) 
 
 
 
 
 
 
   
 
 
 
 
Figure 12 - (Group-III) DEN Induced rat                   Figure.13 - (Group-IV) HESP + DEN  
                            (400x)                                                                      treated rat (400x) 
 
  
 
MORPHOLOGICAL EXAMINATION 
 
 
 
Figure 14 - (Group-I) Control rat 
 
 
 
Figure 15 - (Group-III) DEN Induced rat 
  
 
 
 
 
 
Figure.16 - (Group-IV) DEN+HESP treated rat 
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